Chuang V T, Kuniyasu A, Nakayama H, Matsushita Y, Hirono S, Otagiri M
Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto, Japan.
Biochim Biophys Acta. 1999 Sep 14;1434(1):18-30. doi: 10.1016/s0167-4838(99)00174-0.
It is well known that the subdomain III A (site II) of human serum albumin (HSA) binds a variety of endogenous and exogenous substances. However, the nature of the microenvironment of the binding site remains unclear. Ketoprofen (KP), an arylpropionic acid NSAID which contains a benzophenone moiety, was used as a photoaffinity labeling agent to label the binding region. Subsequent CNBr cleavage of the photolabeled HSA revealed that the 11.6 kDa and 9.4 kDa fragments contained most of the incorporated radioactivity. Competition experiments showed that the 11.6 kDa fragment contains the common binding region for site II ligands. This fragment was redigested with Achromobacter lyticus protease I (AP-I) and the amino acid sequence of the photolabeled peptide was determined to be XCTESLVNRR, which corresponds to the sequence 476C-485K of HSA. The complete amino acid sequence of the corresponding AP-I digested HSA peptide encompasses residues 476 to 499, which form helices 5 and 6 of subdomain III A. The HSA-Myr X-ray crystallography data showed that helix 5 is involved to the least extent in ligand binding. A docking model provided further support that helix 6 represents the photolabeled region of KP.
众所周知,人血清白蛋白(HSA)的亚结构域 III A(位点 II)能结合多种内源性和外源性物质。然而,结合位点微环境的性质仍不清楚。酮洛芬(KP)是一种含有二苯甲酮部分的芳基丙酸类非甾体抗炎药,被用作光亲和标记剂来标记结合区域。随后对光标记的 HSA 进行溴化氰裂解,结果显示 11.6 kDa 和 9.4 kDa 的片段含有大部分掺入的放射性。竞争实验表明,11.6 kDa 的片段包含位点 II 配体的共同结合区域。该片段用溶菌无色杆菌蛋白酶 I(AP-I)再次消化,并确定光标记肽的氨基酸序列为 XCTESLVNRR,它对应于 HSA 的 476C - 485K 序列。相应的经 AP-I 消化的 HSA 肽的完整氨基酸序列涵盖 476 至 499 位残基,它们形成亚结构域 III A 的螺旋 5 和螺旋 6。HSA - Myr X 射线晶体学数据表明,螺旋 5 参与配体结合的程度最小。一个对接模型进一步支持螺旋 6 代表 KP 的光标记区域。